Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Collagen disease. Autoimmune disease]

N Hashimoto1

  • 13rd Department of Internal Medicine, Jikei University, School of Medicine, Tokyo.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|June 1, 1995
PubMed
Summary

This paper discusses a set of guidelines for diagnosing collagen diseases using clinical laboratory tests. These conditions are autoimmune and can present with a range of symptoms. The guidelines, developed by the Japan Society of Clinical Pathology, suggest a stepwise approach to testing. Initial tests include urinalysis, hematology, and inflammatory markers. If suspicion remains high, the authors recommend primary screening tests like rheumatoid factor and anti-nuclear factor. Specific tests for conditions like SLE include anti-Sm antibody and kidney biopsy. The paper highlights the importance of interpreting test results carefully and suggests that the guidelines should be updated to reflect new developments in diagnostic testing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superficial temporal artery to anterior cerebral artery direct anastomosis in patients with moyamoya disease.

Clinical neurology and neurosurgery·1997
Same author

Mechanism of intracranial rebleeding in moyamoya disease.

Clinical neurology and neurosurgery·1997
Same author

Direct surgery for major artery aneurysm associated with moyamoya disease.

Clinical neurology and neurosurgery·1997
Same author

A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: consistent chromosomal abnormalities and temporary C-MYC gene amplification.

Cancer genetics and cytogenetics·1997
Same author

Platelet-derived growth factor-BB, but not -AA, prevents delayed neuronal death after forebrain ischemia in rats.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·1997
Same author

Characteristics of protein kinase C-independent exocytosis in human platelets.

Thrombosis research·1997

Area of Science:

  • Autoimmune disease diagnostics
  • Clinical pathology guidelines
  • Rheumatology

Background:

Autoimmune conditions remain a diagnostic challenge due to overlapping symptoms and variable laboratory findings. While prior research has shown the value of specific biomarkers in identifying immune disorders, no single test provides a definitive diagnosis. This uncertainty drives the need for structured testing protocols in primary care settings. Standardized approaches to laboratory testing can improve diagnostic accuracy and reduce delays in treatment. However, gaps remain in how clinicians interpret and sequence these tests. The Japan Society of Clinical Pathology aimed to address this by developing a set of recommendations. These guidelines were created through expert consensus and published in 1990. Their goal was to provide a clear framework for clinicians to follow in daily practice. This paper evaluates the usefulness and limitations of the proposed testing strategy.

Purpose Of The Study:

The study aimed to clarify the role of clinical laboratory tests in diagnosing collagen diseases. It focused on how to select and interpret essential tests in primary medical settings. The authors wanted to highlight the importance of a stepwise testing approach. They emphasized the need to balance sensitivity and specificity in test selection. The paper also sought to identify areas where the existing guidelines could be improved. It examined the diagnostic value of urinalysis, hematology, and inflammatory markers. The authors proposed a two-stage testing process for suspected cases. Their goal was to provide practical guidance for clinicians managing autoimmune conditions.

Keywords:
collagen disease testingautoimmune disease diagnosisclinical laboratory guidelinesSLE diagnostic methods

Frequently Asked Questions

The first step involves urinalysis, hematology, ESR, and CRP to detect initial abnormalities.

Primary screening includes rheumatoid factor, ANF, anti-DNA antibody, and the LE test.

A stepwise approach reduces unnecessary testing and improves diagnostic accuracy by prioritizing essential tests.

The Coombs test is used to detect immune-mediated hemolysis, particularly in SLE cases.

Related Experiment Videos

Main Methods:

The research team reviewed the 1990 guidelines developed by the Japan Society of Clinical Pathology. They analyzed the structure of the testing algorithm and its clinical application. The guidelines were discussed by a subcommittee over multiple sessions. The final version was published after consensus was reached among experts. The paper outlines a diagnostic workflow for collagen diseases. It begins with basic tests like urinalysis and hematology. If suspicion remains high, the authors recommend primary screening tests. These include rheumatoid factor, ANF, and anti-DNA antibody testing.

Main Results:

The guidelines suggest starting with urinalysis, hematology, ESR, and CRP in suspected cases. These tests often show abnormal results in collagen diseases. If initial findings are inconclusive, the authors recommend further screening. Primary screening tests include rheumatoid factor and anti-nuclear factor. Anti-DNA antibody and LE test are also part of the initial panel. For high suspicion cases, specific tests like anti-Sm antibody are advised. Kidney biopsy and Coombs test are recommended for SLE confirmation. The paper highlights the importance of interpreting test results in context.

Conclusions:

The authors emphasize the need for careful test interpretation in collagen disease diagnosis. They note that no single test can confirm these conditions. The guidelines provide a structured approach for primary care clinicians. The paper acknowledges the limitations of the current testing framework. It suggests that the guidelines require further discussion and revision. The authors call for updated recommendations to reflect new diagnostic tools. They stress the importance of a stepwise testing strategy. Their findings support the value of standardized testing protocols in clinical practice.

Failed At:

2026-07-14T07:44:25.547826+00:00

The paper notes that the guideline was published in 1990 and should be revised after four years.

The authors suggest the framework needs further discussion and revision to improve diagnostic accuracy.